Director of Merrimack Pharmaceuticals Inc (NASDAQ:MACK), Andersen Eric, buys 47,300 shares worth $313,736
According to Merrimack Pharmaceuticals Inc's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Apr 16 04:05 PM, company Director, Andersen Eric disclosed buying 47,300 shares at a cost of $6.63. At the time of this transaction (Apr 14), this trade was worth $313,736 in total. As of Apr 14, Andersen Eric now owns 947,396 shares in total worth about $6,650,719.92.
For the last few recent trades made by Merrimack Pharmaceuticals Inc (NASDAQ:MACK) Director, Andersen Eric, we have the following information:
- SEC Form 4 filing: Apr 13: Bought 9,874 shares at the rate of $6.26 per share. Total worth of this trade was $61,780. Total number of shares owned as of Apr 13 were 906,591
- SEC Form 4 filing: Apr 12: Bought 23,629 shares at the rate of $6.06 per share. Total worth of this trade was $143,194. Total number of shares owned as of Apr 12 were 896,717
- SEC Form 4 filing: Nov 24: Bought 69,088 shares at the rate of $3.65 per share. Total worth of this trade was $252,171. Total number of shares owned as of Nov 24 were 873,088
Posted by
George Daniels
on Saturday April 17 2021, 5:42 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
